IMS Health
Search results
IQVIA Connected Intelligence™. From connecting our data, expertise, and technologies to bringing the right stakeholders together, IQVIA is committed to making connections that help customers accelerate results and improve patient outcomes. Learn more about IQVIA Connected Intelligence.
Singapore is IQVIA's Asia Pacific headquarters and home to one of its five central labs in the region. Its team of more than 400 staff in Singapore provide services, technology solutions and market insights to biopharma and healthcare customers, and oversee IQVIA's operations across the region.
IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward.
IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.
Not only are we making a positive impact on patient lives, but we are learning from each other while doing it. At IQVIA, we have every growth opportunity at our fingertips — we can work with people across the world, enjoy a supportive culture, and at the end of the day, improve global healthcare.
IQVIA Asia Pacific | 59,547 followers on LinkedIn. The Human Data Science Company™ | IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical...
IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise.
Search our Job Opportunities at IQVIA. Not ready to apply? Join our Global Talent Network. 1164 Jobs. R1425842.
Jul 21, 2022 · Revenue for the first six months of 2022 was $7,109 million, up 3.8 percent on a reported basis and 6.9 percent at constant currency compared to the first six months of 2021. TAS revenue was $2,847 million, representing growth of 5.4 percent reported and 9.6 percent at constant currency.
